10 Participants Needed

Vibrotactile Stimulation for Parkinson's Disease

KP
JY
JK
Overseen ByJessica K Yankulova
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial is testing a new treatment called Vibrotactile Coordinated Reset stimulation (vCR) using a device known as the Stanford Glove. It targets Parkinson's Disease patients who have had surgery but still struggle with symptoms. The treatment uses vibrations to help reset brain activity and improve symptoms without the need for invasive procedures.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, since the study involves a non-invasive treatment, it might not require stopping other medications. Please consult with the trial coordinators for specific guidance.

Is vibrotactile stimulation safe for humans?

Research shows that vibrotactile stimulation is generally safe and well tolerated in humans, with studies indicating no significant safety concerns when used for Parkinson's disease.12345

How does the Vibrotactile Coordinated Reset treatment differ from other treatments for Parkinson's Disease?

Vibrotactile Coordinated Reset (vCR) is unique because it is a non-invasive treatment that uses gentle vibrations on the fingertips to reduce abnormal brain synchronization, which is a key issue in Parkinson's Disease. Unlike traditional treatments that often involve medication or invasive procedures, vCR aims to provide long-lasting relief from motor symptoms by 'unlearning' abnormal brain patterns through regular, non-invasive stimulation.12567

What data supports the effectiveness of the treatment Vibrotactile Coordinated Reset for Parkinson's Disease?

Research shows that Vibrotactile Coordinated Reset (vCR) can reduce abnormal brain rhythms and improve motor symptoms in Parkinson's patients. Studies have demonstrated that vCR leads to sustained motor relief and reduces tremor severity, indicating its potential effectiveness as a non-invasive treatment.12456

Are You a Good Fit for This Trial?

This trial is for Parkinson's Disease patients aged 35-90 in the U.S. who've had surgery (not DBS) for their condition, are comfortable with technology, and have support during off states. Excluded are those with severe psychiatric issues, substance abuse, recent or concurrent trial participation, pregnancy intentions, communication difficulties due to speech problems, excessive drooling or fingertip sensory abnormalities.

Inclusion Criteria

I am between 35 and 92 years old.
I have been diagnosed with Parkinson's disease.
Lives in the United States
See 4 more

Exclusion Criteria

My Parkinson's disease symptoms are so severe that I am confined to bed.
I feel unusual sensations in my fingertips.
Pregnancy, breast-feeding or wanting to become pregnant
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Vibrotactile Coordinated Reset stimulation using the Stanford Glove

24 months
Regular visits as per study protocol

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Vibrotactile Coordinated Reset
Trial Overview The study tests a non-invasive treatment called Vibrotactile Coordinated Reset (vCR), delivered through a device named vibrotactile axon Glove. It aims to offer an alternative to levodopa or deep brain stimulation for post-surgery PD patients. Participants will be monitored over two years to assess vCR's effectiveness.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Vibrotactile Coordinated Reset (vCR)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

Published Research Related to This Trial

A new non-invasive treatment called vibrotactile coordinated reset (vCR) aims to improve motor and non-motor symptoms in Parkinson's disease (PD) patients by delivering gentle vibrations to the fingertips, with a 7-month study involving 30 participants to assess its efficacy.
The study will measure the effects of vCR on motor abilities using the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and other evaluations, with the goal of providing evidence for FDA clearance of this innovative therapy.
Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol.Pfeifer, KJ., Cook, AJ., Yankulova, JK., et al.[2023]
Coordinated reset stimulation (CRS) can effectively reduce abnormal brain synchronization associated with Parkinson's disease, as shown in pre-clinical and clinical studies involving parkinsonian monkeys and patients.
The study introduces noninvasive CRS methods using vibrotactile stimulation on fingertips, targeting various mechanoreceptors, which could provide a new avenue for therapeutic intervention in brain disorders.
Vibrotactile Coordinated Reset Stimulation for the Treatment of Neurological Diseases: Concepts and Device Specifications.Tass, PA.[2020]
In two feasibility studies involving eight Parkinson's disease patients, both regular and noisy vibrotactile coordinated reset (vCR) stimulation significantly improved motor abilities without any reported side effects.
EEG recordings from one study indicated that noisy vCR therapy led to a significant reduction in high beta power in the sensorimotor cortex, suggesting it effectively modulates neuronal activity related to motor function.
Coordinated Reset Vibrotactile Stimulation Induces Sustained Cumulative Benefits in Parkinson's Disease.Pfeifer, KJ., Kromer, JA., Cook, AJ., et al.[2023]

Citations

Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol. [2023]
Vibrotactile Coordinated Reset Stimulation for the Treatment of Neurological Diseases: Concepts and Device Specifications. [2020]
Coordinated Reset Vibrotactile Stimulation Induces Sustained Cumulative Benefits in Parkinson's Disease. [2023]
Focused Vibrotactile Stimulation with Cueing Effect on Freezing of Gait in Parkinson's Disease: Two Case Reports. [2021]
Safety and Tolerability of a Wearable, Vibrotactile Stimulation Device for Parkinson's Disease. [2021]
Towards non-invasive peripheral stimulation as a treatment for Parkinson's disease gait. [2023]
Vibrotactile Feedback Alters Dynamics Of Static Postural Control In Persons With Parkinson's Disease But Not Older Adults At High Fall Risk. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security